 | • レポートコード：GIR-107A12601 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、プラダーウィリー症候群治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。プラダーウィリー症候群治療の種類別市場規模（ベロラニブ、塩酸ベタヒスチン、ジアゾキシドコリンCR、FE-992097、NOX-B11、その他）、用途別市場規模（クリニック、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・プラダーウィリー症候群治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Chong Kun Dang Pharmaceutical Corp.、Essentialis, Inc.、Ferring International Center S.A.、LG Life Sciences, Ltd.、P2D Bioscience、Pfizer Inc.、Rhythm Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ベロラニブ、塩酸ベタヒスチン、ジアゾキシドコリンCR、FE-992097、NOX-B11、その他 ・用途別分析2016年-2026年：クリニック、病院、その他 ・プラダーウィリー症候群治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・プラダーウィリー症候群治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・プラダーウィリー症候群治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・プラダーウィリー症候群治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・プラダーウィリー症候群治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Prader-Willi Syndrome Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Prader-Willi Syndrome Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Prader-Willi Syndrome Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Prader-Willi Syndrome Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Beloranib
Betahistine Hydrochloride
Diazoxide Choline CR
FE-992097
NOX-B11
Others
Market segment by Application, can be divided into
Clinic
Hospital
Others
Market segment by players, this report covers
Chong Kun Dang Pharmaceutical Corp.
Essentialis, Inc.
Ferring International Center S.A.
LG Life Sciences, Ltd.
P2D Bioscience
Pfizer Inc.
Rhythm Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prader-Willi Syndrome Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prader-Willi Syndrome Therapeutics, with revenue, gross margin and global market share of Prader-Willi Syndrome Therapeutics from 2019 to 2021.
Chapter 3, the Prader-Willi Syndrome Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Prader-Willi Syndrome Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Prader-Willi Syndrome Therapeutics research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Prader-Willi Syndrome Therapeutics
1.2 Classification of Prader-Willi Syndrome Therapeutics by Type
1.2.1 Overview: Global Prader-Willi Syndrome Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Type in 2020
1.2.3 Beloranib
1.2.4 Betahistine Hydrochloride
1.2.5 Diazoxide Choline CR
1.2.6 FE-992097
1.2.7 NOX-B11
1.2.8 Others
1.3 Global Prader-Willi Syndrome Therapeutics Market by Application
1.3.1 Overview: Global Prader-Willi Syndrome Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Prader-Willi Syndrome Therapeutics Market Size & Forecast
1.5 Global Prader-Willi Syndrome Therapeutics Market Size and Forecast by Region
1.5.1 Global Prader-Willi Syndrome Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prader-Willi Syndrome Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Prader-Willi Syndrome Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Prader-Willi Syndrome Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Prader-Willi Syndrome Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prader-Willi Syndrome Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prader-Willi Syndrome Therapeutics Market Drivers
1.6.2 Prader-Willi Syndrome Therapeutics Market Restraints
1.6.3 Prader-Willi Syndrome Therapeutics Trends Analysis
2 Company Profiles
2.1 Chong Kun Dang Pharmaceutical Corp.
2.1.1 Chong Kun Dang Pharmaceutical Corp. Details
2.1.2 Chong Kun Dang Pharmaceutical Corp. Major Business
2.1.3 Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Product and Solutions
2.1.4 Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Chong Kun Dang Pharmaceutical Corp. Recent Developments and Future Plans
2.2 Essentialis, Inc.
2.2.1 Essentialis, Inc. Details
2.2.2 Essentialis, Inc. Major Business
2.2.3 Essentialis, Inc. Prader-Willi Syndrome Therapeutics Product and Solutions
2.2.4 Essentialis, Inc. Prader-Willi Syndrome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Essentialis, Inc. Recent Developments and Future Plans
2.3 Ferring International Center S.A.
2.3.1 Ferring International Center S.A. Details
2.3.2 Ferring International Center S.A. Major Business
2.3.3 Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Product and Solutions
2.3.4 Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Ferring International Center S.A. Recent Developments and Future Plans
2.4 LG Life Sciences, Ltd.
2.4.1 LG Life Sciences, Ltd. Details
2.4.2 LG Life Sciences, Ltd. Major Business
2.4.3 LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Product and Solutions
2.4.4 LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 LG Life Sciences, Ltd. Recent Developments and Future Plans
2.5 P2D Bioscience
2.5.1 P2D Bioscience Details
2.5.2 P2D Bioscience Major Business
2.5.3 P2D Bioscience Prader-Willi Syndrome Therapeutics Product and Solutions
2.5.4 P2D Bioscience Prader-Willi Syndrome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 P2D Bioscience Recent Developments and Future Plans
2.6 Pfizer Inc.
2.6.1 Pfizer Inc. Details
2.6.2 Pfizer Inc. Major Business
2.6.3 Pfizer Inc. Prader-Willi Syndrome Therapeutics Product and Solutions
2.6.4 Pfizer Inc. Prader-Willi Syndrome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Pfizer Inc. Recent Developments and Future Plans
2.7 Rhythm Pharmaceuticals
2.7.1 Rhythm Pharmaceuticals Details
2.7.2 Rhythm Pharmaceuticals Major Business
2.7.3 Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Product and Solutions
2.7.4 Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Rhythm Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prader-Willi Syndrome Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Prader-Willi Syndrome Therapeutics Players Market Share
3.2.2 Top 10 Prader-Willi Syndrome Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Prader-Willi Syndrome Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prader-Willi Syndrome Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Prader-Willi Syndrome Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Prader-Willi Syndrome Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prader-Willi Syndrome Therapeutics Revenue by Type (2016-2026)
6.2 North America Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2026)
6.3 North America Prader-Willi Syndrome Therapeutics Market Size by Country
6.3.1 North America Prader-Willi Syndrome Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prader-Willi Syndrome Therapeutics Revenue by Type (2016-2026)
7.2 Europe Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2026)
7.3 Europe Prader-Willi Syndrome Therapeutics Market Size by Country
7.3.1 Europe Prader-Willi Syndrome Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Region
8.3.1 Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue by Region (2016-2026)
8.3.2 China Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prader-Willi Syndrome Therapeutics Revenue by Type (2016-2026)
9.2 South America Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2026)
9.3 South America Prader-Willi Syndrome Therapeutics Market Size by Country
9.3.1 South America Prader-Willi Syndrome Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Country
10.3.1 Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Prader-Willi Syndrome Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Prader-Willi Syndrome Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prader-Willi Syndrome Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prader-Willi Syndrome Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prader-Willi Syndrome Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Chong Kun Dang Pharmaceutical Corp. Corporate Information, Head Office, and Major Competitors
Table 7. Chong Kun Dang Pharmaceutical Corp. Major Business
Table 8. Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Product and Solutions
Table 9. Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Essentialis, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Essentialis, Inc. Major Business
Table 12. Essentialis, Inc. Prader-Willi Syndrome Therapeutics Product and Solutions
Table 13. Essentialis, Inc. Prader-Willi Syndrome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Ferring International Center S.A. Corporate Information, Head Office, and Major Competitors
Table 15. Ferring International Center S.A. Major Business
Table 16. Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Product and Solutions
Table 17. Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. LG Life Sciences, Ltd. Corporate Information, Head Office, and Major Competitors
Table 19. LG Life Sciences, Ltd. Major Business
Table 20. LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Product and Solutions
Table 21. LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. P2D Bioscience Corporate Information, Head Office, and Major Competitors
Table 23. P2D Bioscience Major Business
Table 24. P2D Bioscience Prader-Willi Syndrome Therapeutics Product and Solutions
Table 25. P2D Bioscience Prader-Willi Syndrome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Inc. Major Business
Table 28. Pfizer Inc. Prader-Willi Syndrome Therapeutics Product and Solutions
Table 29. Pfizer Inc. Prader-Willi Syndrome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Rhythm Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. Rhythm Pharmaceuticals Major Business
Table 32. Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Product and Solutions
Table 33. Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Prader-Willi Syndrome Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 35. Global Prader-Willi Syndrome Therapeutics Revenue Share by Players (2019-2021)
Table 36. Breakdown of Prader-Willi Syndrome Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Prader-Willi Syndrome Therapeutics Players Head Office, Products and Services Provided
Table 38. Prader-Willi Syndrome Therapeutics Mergers & Acquisitions in the Past Five Years
Table 39. Prader-Willi Syndrome Therapeutics New Entrants and Expansion Plans
Table 40. Global Prader-Willi Syndrome Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 41. Global Prader-Willi Syndrome Therapeutics Revenue Share by Type (2016-2021)
Table 42. Global Prader-Willi Syndrome Therapeutics Revenue Forecast by Type (2021-2026)
Table 43. Global Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2021)
Table 44. Global Prader-Willi Syndrome Therapeutics Revenue Forecast by Application (2021-2026)
Table 45. North America Prader-Willi Syndrome Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Prader-Willi Syndrome Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Prader-Willi Syndrome Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Prader-Willi Syndrome Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Prader-Willi Syndrome Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Prader-Willi Syndrome Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Prader-Willi Syndrome Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Prader-Willi Syndrome Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Prader-Willi Syndrome Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Prader-Willi Syndrome Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Prader-Willi Syndrome Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Prader-Willi Syndrome Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Prader-Willi Syndrome Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Prader-Willi Syndrome Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Prader-Willi Syndrome Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Prader-Willi Syndrome Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prader-Willi Syndrome Therapeutics Picture
Figure 2. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Type in 2020
Figure 3. Beloranib
Figure 4. Betahistine Hydrochloride
Figure 5. Diazoxide Choline CR
Figure 6. FE-992097
Figure 7. NOX-B11
Figure 8. Others
Figure 9. Prader-Willi Syndrome Therapeutics Revenue Market Share by Application in 2020
Figure 10. Clinic Picture
Figure 11. Hospital Picture
Figure 12. Others Picture
Figure 13. Global Prader-Willi Syndrome Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Prader-Willi Syndrome Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Region (2016-2026)
Figure 16. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Region in 2020
Figure 17. North America Prader-Willi Syndrome Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Prader-Willi Syndrome Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Prader-Willi Syndrome Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Prader-Willi Syndrome Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Prader-Willi Syndrome Therapeutics Market Drivers
Figure 23. Prader-Willi Syndrome Therapeutics Market Restraints
Figure 24. Prader-Willi Syndrome Therapeutics Market Trends
Figure 25. Chong Kun Dang Pharmaceutical Corp. Recent Developments and Future Plans
Figure 26. Essentialis, Inc. Recent Developments and Future Plans
Figure 27. Ferring International Center S.A. Recent Developments and Future Plans
Figure 28. LG Life Sciences, Ltd. Recent Developments and Future Plans
Figure 29. P2D Bioscience Recent Developments and Future Plans
Figure 30. Pfizer Inc. Recent Developments and Future Plans
Figure 31. Rhythm Pharmaceuticals Recent Developments and Future Plans
Figure 32. Global Prader-Willi Syndrome Therapeutics Revenue Share by Players in 2020
Figure 33. Prader-Willi Syndrome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Prader-Willi Syndrome Therapeutics Revenue Market Share in 2020
Figure 35. Global Top 10 Players Prader-Willi Syndrome Therapeutics Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Prader-Willi Syndrome Therapeutics Revenue Share by Type in 2020
Figure 38. Global Prader-Willi Syndrome Therapeutics Market Share Forecast by Type (2021-2026)
Figure 39. Global Prader-Willi Syndrome Therapeutics Revenue Share by Application in 2020
Figure 40. Global Prader-Willi Syndrome Therapeutics Market Share Forecast by Application (2021-2026)
Figure 41. North America Prader-Willi Syndrome Therapeutics Sales Market Share by Type (2016-2026)
Figure 42. North America Prader-Willi Syndrome Therapeutics Sales Market Share by Application (2016-2026)
Figure 43. North America Prader-Willi Syndrome Therapeutics Revenue Market Share by Country (2016-2026)
Figure 44. United States Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Prader-Willi Syndrome Therapeutics Sales Market Share by Type (2016-2026)
Figure 48. Europe Prader-Willi Syndrome Therapeutics Sales Market Share by Application (2016-2026)
Figure 49. Europe Prader-Willi Syndrome Therapeutics Revenue Market Share by Country (2016-2026)
Figure 50. Germany Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Prader-Willi Syndrome Therapeutics Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Prader-Willi Syndrome Therapeutics Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Prader-Willi Syndrome Therapeutics Revenue Market Share by Region (2016-2026)
Figure 58. China Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Prader-Willi Syndrome Therapeutics Sales Market Share by Type (2016-2026)
Figure 65. South America Prader-Willi Syndrome Therapeutics Sales Market Share by Application (2016-2026)
Figure 66. South America Prader-Willi Syndrome Therapeutics Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Prader-Willi Syndrome Therapeutics Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Prader-Willi Syndrome Therapeutics Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Prader-Willi Syndrome Therapeutics Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Prader-Willi Syndrome Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のレット症候群市場 2021：企業別、地域別、種類・用途別 The Rett Syndrome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…- 世界のゾリンジャー-エリソン症候群検査市場 2021：企業別、地域別、種類・用途別 The Zollinger - Ellison Syndrome Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のトゥレット症候群治療薬市場 2021：企業別、地域別、種類・用途別 The Tourette Syndrome Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界のシェーグレン症候群治療薬市場 2021：企業別、地域別、種類・用途別 The Sicca Syndrome Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の非定型溶血性尿毒症症候群治療薬市場 2021：企業別、地域別、種類・用途別 The Atypical Hemolytic Uremic Syndrome Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…